CG
Cutler Group’s Moderna MRNA Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | $13K | Buy |
130
+80
| +160% | +$8K | ﹤0.01% | 589 |
|
2023
Q4 | $4K | Sell |
50
-4,992
| -99% | -$399K | ﹤0.01% | 1118 |
|
2023
Q3 | $520K | Sell |
5,042
-3,182
| -39% | -$328K | 0.05% | 241 |
|
2023
Q2 | $999K | Sell |
8,224
-3,351
| -29% | -$407K | 0.14% | 109 |
|
2023
Q1 | $1.78M | Sell |
11,575
-38,121
| -77% | -$5.85M | 0.18% | 81 |
|
2022
Q4 | $8.93M | Buy |
49,696
+38,531
| +345% | +$6.92M | 0.75% | 13 |
|
2022
Q3 | $1.32M | Sell |
11,165
-34,793
| -76% | -$4.11M | 0.09% | 122 |
|
2022
Q2 | $6.57M | Sell |
45,958
-20,882
| -31% | -$2.98M | 0.46% | 14 |
|
2022
Q1 | $11.5M | Buy |
66,840
+64,550
| +2,819% | +$11.1M | 0.61% | 10 |
|
2021
Q4 | $581K | Buy |
+2,290
| New | +$581K | 0.02% | 365 |
|
2021
Q3 | – | Sell |
-700
| Closed | -$164K | – | 2506 |
|
2021
Q2 | $164K | Sell |
700
-1,327
| -65% | -$311K | 0.01% | 801 |
|
2021
Q1 | $265K | Buy |
2,027
+747
| +58% | +$97.7K | 0.01% | 579 |
|
2020
Q4 | $133K | Buy |
1,280
+1,000
| +357% | +$104K | 0.01% | 694 |
|
2020
Q3 | $19K | Sell |
280
-3,580
| -93% | -$243K | ﹤0.01% | 1156 |
|
2020
Q2 | $247K | Sell |
3,860
-2,364
| -38% | -$151K | 0.02% | 388 |
|
2020
Q1 | $186K | Buy |
6,224
+3,224
| +107% | +$96.3K | 0.01% | 445 |
|
2019
Q4 | $58K | Sell |
3,000
-1,360
| -31% | -$26.3K | ﹤0.01% | 849 |
|
2019
Q3 | $69K | Buy |
4,360
+2,360
| +118% | +$37.3K | 0.01% | 708 |
|
2019
Q2 | $29K | Buy |
+2,000
| New | +$29K | ﹤0.01% | 1068 |
|
2019
Q1 | – | Sell |
-100
| Closed | -$1K | – | 1937 |
|
2018
Q4 | $1K | Buy |
+100
| New | +$1K | ﹤0.01% | 1529 |
|